Bookmark and Share
Australian Prescriber
  • Home
  • About us
    • Who we are
    • What we do
    • Editorial executive committe
    • Advisory editorial panel
    • AP Video
  • Contact us
    • Subscription
    • Email alert
    • Write to Australian Prescriber
  • Index
    • Subject index
    • Author index
  • For consumers
    • Comments
    • Articles
    • Patient perspectives
    • Support organisations
    • News
  • Archive
    • Back Issues
    • Media releases
    • Past covers
Volume 21 Number 4 - October 1998
The role of HMG CoA reductase inhibitors after myocardial infarction
(Editorial) A. M. Tonkin & E. W. Ryan
-
Letters to the editor
-
Strategies to assist patient compliance with lifestyle changes
G. Brokensha
-
Angiotensin receptor antagonists for the treatment of hypertension
C. I. Johnston
-
Book review
Therapeutic guidelines: antibiotic. 10th edition
-
Your questions to the PBAC
-
Sheffield tables for primary prevention of coronary heart disease - an alternative approach
R. F. W. Moulds
-
Eating disorders: anorexia nervosa, bulimia nervosa and related syndromes - an overview of assessment and management
P. J. Hay
-
Patient perspective
Eating disorders: the patient's perspective
-
Patient support organisation
Eating Disorders
-
Top 10 drugs
-
The regulation of complementary medicines by the Therapeutic Goods Administration
H. Cameron
-
New drugs
montelukast sodium
naratriptan
pertussis, diphtheria and tetanus
remifentanil
sildenafil citrate
tramadol hydrochloride
zolmitriptan

-
Get Adobe Acrobat
Australian Prescriber Cover
HomeHome Contact usContact us Free subscriptionFree subscription Useful linksUseful links User guideUser guide Legal informationLegal information Privacy noticePrivacy notice Web manager